CHECKMATE GOVERNMENT RELATIONS

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · $90,000.00 income · posted Jul 20, 2025

Lobbying activity 1

Health Issues

There is no current bill filed. Issues related to anti-obesity medications, drug pricing, and pharmaceutical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.